Skip to main content
Top
Published in: Translational Behavioral Medicine 1/2014

01-03-2014 | News

News from the NIH: improving health and reducing premature mortality in people with serious mental illnesses

Authors: Susan T Azrin, PhD, David A Chambers, DPhil

Published in: Translational Behavioral Medicine | Issue 1/2014

Login to get access

Excerpt

People with serious mental illness1 (SMI), also sometimes referred to as “severe mental illness,” die from the same causes as those in the general population, e.g., heart disease, diabetes, cancer, stroke, and pulmonary disease. However, these diseases are more common in people with SMI and lead to earlier death. For example, adults with psychotic disorders die, on average, 11 years earlier than adults with no mental disorder, most often from these co-morbid medical conditions [1]. The modifiable health risk factors that contribute to these diseases—smoking, obesity, hypertension, metabolic disorder, low physical activity, substance use, poor fitness, and diet—are also more common and have an earlier onset in people with SMI [2]. The 11.5 million adults with SMI in the USA are disproportionately affected by these modifiable health risk factors, and their low rates of prevention, detection, and treatment result in substantial disease burden and premature mortality [13]. Effective interventions to reduce these health risk factors exist for the general population, but they are generally unavailable to people with SMI. The National Institute of Mental Health (NIMH) and other Institutes recognize the need for research to develop and test interventions that aim to eliminate excess morbidity and mortality in people with SMI. This column highlights key activities that NIMH and other institutes have undertaken in this effort, including trans-institute meetings, funding opportunities, and resource development. …
Footnotes
1
By “serious mental illness,” we mean a diagnosable psychiatric disorder resulting in functional impairment that substantially interferes with or limits major life activities.
 
Literature
1.
go back to reference Druss BG, Zhao L, Von Esenwein S, et al. Understanding excess mortality in persons with mental illness: 17-year follow up of a nationally representative US survey. Med Care. 2011; 49(6): 599-604.PubMedCrossRef Druss BG, Zhao L, Von Esenwein S, et al. Understanding excess mortality in persons with mental illness: 17-year follow up of a nationally representative US survey. Med Care. 2011; 49(6): 599-604.PubMedCrossRef
2.
go back to reference SAMHSA. Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008–2010. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2010. SAMHSA. Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008–2010. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2010.
3.
go back to reference Substance Abuse and Mental Health Services Administration. Results from the 2011 National Survey on Drug Use and Health: Mental Health Findings, NSDUH Series H-45, HHS Publication No. (SMA). Rockville, MD: Substance Abuse and Mental Health Services Administration; 2012: 12-4725. Substance Abuse and Mental Health Services Administration. Results from the 2011 National Survey on Drug Use and Health: Mental Health Findings, NSDUH Series H-45, HHS Publication No. (SMA). Rockville, MD: Substance Abuse and Mental Health Services Administration; 2012: 12-4725.
4.
go back to reference Nasrallah HA, Meyer JM, Goff DC, et al. Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: Data from the CATIE schizophrenia trial sample at baseline. Schizophr Res. 2006; 86(1–3): 15-22.PubMedCrossRef Nasrallah HA, Meyer JM, Goff DC, et al. Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: Data from the CATIE schizophrenia trial sample at baseline. Schizophr Res. 2006; 86(1–3): 15-22.PubMedCrossRef
5.
go back to reference Goff DC, Sullivan LM, McEvoy JP, et al. A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophr Res. 2005; 80(1): 45-53.PubMedCrossRef Goff DC, Sullivan LM, McEvoy JP, et al. A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophr Res. 2005; 80(1): 45-53.PubMedCrossRef
Metadata
Title
News from the NIH: improving health and reducing premature mortality in people with serious mental illnesses
Authors
Susan T Azrin, PhD
David A Chambers, DPhil
Publication date
01-03-2014
Publisher
Springer US
Published in
Translational Behavioral Medicine / Issue 1/2014
Print ISSN: 1869-6716
Electronic ISSN: 1613-9860
DOI
https://doi.org/10.1007/s13142-013-0238-8

Other articles of this Issue 1/2014

Translational Behavioral Medicine 1/2014 Go to the issue